Global Craniomaxillofacial Devices Market valued at $2.2 billion (2022), is growing at a decent CAGR of 6.8%

CMF devices are used during medical surgeries to treat injuries, defects, and diseases in the head, neck, face, jaws, hard and soft tissues of the cranial and maxillofacial region. The CMF devices market consists of implants, software, anatomic models, instruments, and surgical guides.

High incidence of traumatic brain injuries (TBIs) is driving the demand for CMF devices

Head injuries are one of the most common causes of disability and death in adults. According to the Journal of Neurosurgery, 69 million individuals across the world are estimated to sustain a TBI each year. About 2.8 million TBIs occur in the United States every year (Source: CDC). Large number of TBIs and associated skull fractures are driving the demand for CMF devices.

Sports related injuries are propelling the volumes of CMF procedures

The growth in the number of injuries caused due to sports activities is expected to increase the demand for CMF devices. According to John Hopkins Medicine, over 3.5 million sports-related injuries are reported every year in the USA and almost one-third of all injuries incurred in childhood are sports-related injuries.

Rising demand for patient specific implants (PSIs)

The global CMF devices market is dominated by standard/off-the-shelf implants. However, the demand for patient-specific implants is growing. This is attributed to the advances in imaging techniques that allow physicians to recreate a computerized model of the patient's anatomy and provide personalized solutions. Further, improvements in the CMF planning software have added tools that help surgeons make almost any measurement possible and align the bone segments in a perfectly symmetrical manner. This has enabled designing patient specific solutions with high accuracy.

Point of Care (POC) 3D Printing to offer future growth opportunities in CMF Devices Market

Point of care (POC) 3D printing is likely to find high traction in the upcoming years. Hospitals are increasingly looking for POC 3D printing solutions owing to its key benefits like direct communication between engineer and the surgeon and accelerated delivery. Leading Market players such as KLS Martin have already began to focus on POC services. Recently, Charite hospital (Germany) entered into a public-private partnership with KLS Martin. They shared investment for the printers in hospitals and KLS is printing the implants for Charite.

Regional Snapshot: North America leads the adoption of CMF Devices Market

From a geographic perspective, North America has a higher market share of global CMF devices revenues. This is mainly attributed to the large volumes of CMF procedures, high incidence of trauma injuries, relatively greater penetration and reimbursement of CMF products in the region.

Leading market players operating in the global CMF devices market are KLS Martin, DePuy Synthes Companies (JnJ), Stryker, Medartis, Renishaw, Zimmer Biomet, Medtronic, Materialise, Xilloc Medical, Synimed, Medicon, 3D Systems, 3D Life Prints, Nutechnologies, 3Di, among others.

Get Customized Research Report on CMF Devices Market @ https://meditechinsights.com/cmf-craniomaxillofacial-devices-market/

Comments

Post a Comment

Popular posts from this blog

Global Healthcare Companion Robots Market valued at about $3 billion (2020), is growing at a lucrative CAGR close to 20% through 2020-2025

Companion robots offer companionship and emotional support for the children, elderly, and disabled people. Over the years, the improvements in sensors, actuators, and AI have led to rise in interest in healthcare companion robots market. Rising aging population, the rising cost of elder care, and shortage of caregivers The population across the globe is aging and the number of caregivers in relation to the aging population is declining. In Japan, there will be an estimated shortage of 1 million caregivers by 2025. Moreover, the cost of elder care is also rising. Between 2019 and 2020, the cost of in-home care jumped by about 4.4%; assisted living costs surged by 6.2%; and nursing home costs increased by 3%. The use of robots instead could help reduce this cost. For instance, a monthly service contract for Stevie (a robot developed by Trinity College, Dublin) would likely run between 50-60% of the cost of hiring a human to do the same tasks, as per their claim. “The growing dispar...
Read more

Global Mycoplasma Testing Market is slated to see a lucrative growth rate of 11% by 2027

Mycoplasmas are the smallest known free-living microorganisms and are frequent contaminants of mammalian cell cultures. For the safety and purity of vaccines and other biological cell-derived products, it is crucial that the cell substrates and unprocessed bulk materials are free of adventitious agents, including mycoplasma.  In many cases, mycoplasmas vary from other forms of bacteria, making them difficult to culture and identify. Testing is done to detect mycoplasma like Mycoplasma hominis, Mycoplasma genitalium, Mycoplasma pneumoniae, and Ureaplasma urealyticum which can cause nongonococcal urethritis (NGU), prostate inflammation (prostatitis), vaginal discharge, and pelvic inflammatory disease (PID) in both men and women. Rising Concerns of Cell Culture Contamination to Trigger the Growth of the Global Mycoplasma Testing Market Mycoplasmas randomly contaminate the fluids used in the bioprocessing and cell culture. It is commonly known that primary cell cultures have a minimum...
Read more

Global Obesity Drugs Market valued at $2.3 billion in 2022, is expected to Witness a Healthy Growth of 25% by 2027

Obesity and overweight are defined as gain of additional fat thus leading to a number of diseases, which can be measured by using body mass index (BMI) as a baseline. A BMI of over 30 is generally considered as obese and a BMI of over 25 is considered as overweight. Obesity is a major risk factor to various diseases such as diabetes, heart diseases, and cancer; approximately over 650 million obese patients living across the world as as projected by World Health Organization (WHO). Rising Obese and Overweight Population to Trigger the Demand of Obesity Drugs Market Obesity is one of the topmost contributors to a number of medical diseases such as heart diseases, stroke, cancer and diabetes. World Obesity Atlas 2022 forecasted the growth of global obese population to be 16.1% in 2025, accounting for 892 million people which will further reach 1,025 million by 2030 with a healthy growth rate of 17.5% in 2030.  Some of the regional obesity burden estimated by World Obesity Atlas 202...
Read more